The gold standard is the Abnormal Involuntary Movement Scale, or the AIMS, although generally we kind of want to avoid premature TD labels, and we want to ensure that there's a causal link, in this ...
Findings showed associations between abnormal involuntary movements and biological markers such as regional cerebral blood flow and grey matter volume in a psychiatric sample, indicating a ...
Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with ...
—A Q&A with Joseph P. McEvoy, MD, Case Distinguished Chair in Psychotic Disorders and Professor, Medical College of Georgia, Augusta University Dr. McEvoy enjoys spending time with patients and does ...
SAN DIEGO, Sept. 9, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) announced today that the 50mg dose of NBI-98854, a small molecule VMAT2 inhibitor in development for tardive dyskinesia, ...
SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a small molecule VMAT2 inhibitor, showed a statistically significant and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results